Engineering the IL-4/IL-13 axis for targeted immune modulation.

Bernstein, Zachary J; Shenoy, Anjali; Chen, Amy; Heller, Nicola M; Spangler, Jamie B

Bernstein, Zachary J; Shenoy, Anjali; Chen, Amy; Heller, Nicola M; Spangler, Jamie B.

Afiliación

Bernstein ZJ; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shenoy A; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Chen A; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Heller NM; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Spangler JB; Department of Molecular and Cellular Biology, Johns Hopkins University, Baltimore, Maryland, USA.

Immunol Rev ; 320(1): 29-57, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37283511

Asunto(s)

Interleucina-13; Interleucina-4; Humanos; Interleucina-13/metabolismo; Interleucina-4/metabolismo; Citocinas/metabolismo; Células Th2; Inmunidad

Palabras clave

T cells; allergy; antibody; autoimmune disease; cell therapy; cytokine; dupilumab; interleukin-13; interleukin-4; protein engineering

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-4 / Interleucina-13 Límite: Humans Idioma: En Revista: Immunol Rev Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google